Battle of the GIFs! Zynga Launches GIFs Against Friends on the App Store for iMessage
Apr 20, 2017 13:01 pm UTC| Business
SAN FRANCISCO, April 20, 2017 -- Zynga (Nasdaq:ZNGA), a leading social game developer, today announced the launch of GIFs Against Friends, the ultimate mobile party game and the company’s latest addition to its iMessage...
Battle of the GIFs! Zynga Launches GIFs Against Friends on the App Store for iMessage
Apr 20, 2017 13:01 pm UTC| Business
SAN FRANCISCO, April 20, 2017 -- Zynga (Nasdaq:ZNGA), a leading social game developer, today announced the launch of GIFs Against Friends, the ultimate mobile party game and the company’s latest addition to its iMessage...
Apr 20, 2017 13:01 pm UTC| Business
COLORADO SPRINGS, Colo., April 20, 2017 -- Insurance Technologies, LLC, a provider of sales and automation solutions for the insurance and financial services industries, announced today the latest release of FireLight®,...
Apr 20, 2017 13:01 pm UTC| Business
COLORADO SPRINGS, Colo., April 20, 2017 -- Insurance Technologies, LLC, a provider of sales and automation solutions for the insurance and financial services industries, announced today the latest release of FireLight®,...
Mitel User Group Hosts Elite Experience Event May 30-June 2
Apr 20, 2017 13:01 pm UTC| Business
Headlined by Olympic gold medalist Michael Johnson, President and Founder of Michael Johnson Performance, and Dr. Vijay Gurbaxani, Founding Director of the Center for Digital Transformation at University of California,...
Mitel User Group Hosts Elite Experience Event May 30-June 2
Apr 20, 2017 13:01 pm UTC| Business
Headlined by Olympic gold medalist Michael Johnson, President and Founder of Michael Johnson Performance, and Dr. Vijay Gurbaxani, Founding Director of the Center for Digital Transformation at University of California,...
Adverum Biotechnologies, Inc. Appoints Richard N. Spivey, Pharm.D., Ph.D. to Board of Directors
Apr 20, 2017 13:00 pm UTC| Business
MENLO PARK, Calif., April 20, 2017 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a leading gene therapy company advancing novel medicines to address unmet needs in serious rare and ocular diseases, today announced the...